ArticleFrontiers in cardiovascular medicine2026
Erector spinae density as a predictor of early cardiac complications in patients with stroke.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale and objectives: The relationship between erector spinae muscle density (ESMD) and early cardiovascular complications in patients with stroke remains unexplored. Therefore, this study aimed to evaluate the predictive value of ESMD, assessed through chest computed tomography (CT), for the incidence of stroke-heart syndrome (SHS) in patients with stroke. Materials and methods: Clinical data of 422 patients with stroke from Zhejiang Provincial People's Hospital (January 2023-March 2024) were retrospectively analyzed. Patients were grouped based on the presence of SHS within 72 h of admission. Logistic regression analyses identified predictors, and a nomogram integrating ESMD was constructed. Model performance was evaluated through receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis. Results: Independent predictors of SHS included the ESMD, serum albumin level, estimated glomerular filtration rate, prothrombin time, and fibrinogen level ( Conclusion: ESMD obtained from chest CT is a strong predictor of SHS, offering a practical, non-invasive marker for early risk stratification and management. The proposed nomogram provides an effective tool for identifying and managing patients at high risk of SHS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.